Stay updated on Efficacy and Safety of Cenobamate Adjunctive Therapy in POS Clinical Trial
Sign up to get notified when there's something new on the Efficacy and Safety of Cenobamate Adjunctive Therapy in POS Clinical Trial page.

Latest updates to the Efficacy and Safety of Cenobamate Adjunctive Therapy in POS Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedAdded a Last known status block to the study record showing sponsor SK Life Science, Inc., date 2023-10, and verification status.SummaryDifference0.4%

- Check17 days agoChange DetectedThe updates seem to be superficial UI changes (cookie banner and header/footer adjustments) with no alterations to the study's design, eligibility criteria, primary outcome measures, or enrollment information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check24 days agoChange DetectedAdded a new Publications section featuring a specific PubMed-listed study on cenobamate efficacy in focal seizure subtypes; no deletions were made. This expands authoritative sources on the page.SummaryDifference4%

- Check38 days agoChange DetectedThe page now includes a government-funding notice and the new version tag v3.2.0, replacing the old v3.1.0.SummaryDifference3%

- Check45 days agoChange DetectedAdded new version tag v3.1.0 and removed multiple drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs, etc.), indicating a content consolidation or reorganization with focus shift away from those safety sections.SummaryDifference0.4%

- Check60 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed. No substantive changes to core content, pricing, stock availability, or time-slot information.SummaryDifference0.2%

Stay in the know with updates to Efficacy and Safety of Cenobamate Adjunctive Therapy in POS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy and Safety of Cenobamate Adjunctive Therapy in POS Clinical Trial page.